What You Should Know:
– Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round.
– The round was led by Peter Bauer’s Family Office as part…
Continue Reading
Sujay Jadhav, Verana Health CEO
In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical…
Continue Reading
What You Should Know:
– myTomorrows, a global health technology company connecting patients and physicians with all possible pre-approval treatment options, today announced the launch of its next-generation AI platform.
– Designed to streamline clinical trial…
Continue Reading
Groundbreaking Transformation in Clinical Research
Mayo Clinic’s ambitious Clinical Trials Beyond Walls (CTBW) program represents a paradigm shift in medical research, leveraging cutting-edge telehealth technology and remote assessment capabilities to conduct clinical trials in patients’…
Made possible through pilot funding and informed by user experience research, Mayo Clinic’s Clinical Trials Beyond Walls initiative leverages telehealth, remote assessments and other hospital-at-home innovations to bring all or some trial aspects into…
Continue Reading
What You Should Know:
– Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata’s life sciences clients and expand the…
Continue Reading
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
What You Should Know:
– ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their…
Continue Reading
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials.The…
Continue Reading
Manas AI, an AI-driven drug discovery platform, has launched with $24.6 million in seed round in a round co-led by General Catalyst and LinkedIn cofounder Reid Hoffman. Greylock and other strategic investors participated in the…
Continue Reading
